F-group (family)
10.32.1.29 PA-IL
Ligands and drugs
227
Member domains
221
with ligand contacts (≤ 4 Å)
97.4% of members
193
with DrugDomain annotations
85.0% of members
67
with a DrugBank compound
29.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 10.32.1.29 belongs to X-group 10 jelly-roll, which binds 8.5 ligand superclasses per 20 proteins, broader than 66% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02379 | BGC | Beta-D-Glucose | 22 |
| DB04242 | PHB | 4-hydroxybenzoic acid | 22 |
| DB02100 | AMG | Methyl alpha-galactoside | 8 |
| DB02632 | 147 | 4-nitrophenyl-beta-D-galactoside | 4 |
| DB00323 | TCW | Tolcapone | 2 |
| DB04332 | ETE | 2-{2-[2-2-(Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethanol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CAmetal | CALCIUM ION | 217 |
| GAL | beta-D-galactopyranose | 58 |
| GLA | alpha-D-galactopyranose | 16 |
| PHB | P-HYDROXYBENZOIC ACID | 14 |
| LRD | 2-[(E)-(3-chloro-4-hydroxyphenyl)(3-chloro-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]benzenesulfonic acid | 12 |
| A1I1G | pentyl 3-[3-nitro-4,5-bis(oxidanyl)phenyl]carbonylbenzoate | 8 |
| AMG | methyl alpha-D-galactopyranoside | 8 |
| CN8 | (4S)-N-ethyl-4-{[N-methyl-3-(1-{2-[(4-sulfanylbenzoyl)amino]ethyl}-1H-1,2,3-triazol-4-yl)-L-alanyl]amino}-L-prolinamide | 8 |
| CL | CHLORIDE ION | 7 |
| 04G | 7-hydroxy-3H-phenoxazin-3-one | 4 |
| 147 | 4-nitrophenyl beta-D-galactopyranoside | 4 |
| 4J9 | (2R,3R,4S,5R,6R,2'R,3'R,4'S,5'R,6'R)-2,2'-([(2R,3R,4S,5S,6S)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2,5-diyl]bis{1H-1,2,3-triazole-1,4-diyl[(2S,3R,4S,5S,6S)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2,5-diyl]-1H-1,2,3-triazole-1,4-diylmethanediyloxy})bis[6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol] | 4 |
| 4VH | N-[2-[4-[(2S)-3-(2-hydroxyethylamino)-3-oxidanylidene-2-(2-phenoxyethanoylamino)propyl]-1,2,3-triazol-1-yl]ethyl]-4-[(2S,3R,4S,5R,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]sulfanyl-benzamide | 4 |
| 56N | phenyl beta-D-galactopyranoside | 4 |
| 7NU | phenyl 6,7-anhydro-D-glycero-beta-D-galacto-heptopyranoside | 4 |
| 9TQ | 5-[2-[(2~{S},3~{R},4~{S},5~{R},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxyethylcarbamothioylamino]-2-(6-oxidanyl-3-oxidanylidene-4,9-dihydroxanthen-9-yl)benzoic acid | 4 |
| A1IZM | [2,6-bis(fluoranyl)phenyl]-[3-nitro-4,5-bis(oxidanyl)phenyl]methanone | 4 |
| G0P | N-[(2S)-6-amino-1-oxo-1-(pyrrolidin-1-yl)hexan-2-yl]-4-(beta-D-galactopyranosyloxy)benzamide | 4 |
| GS9 | naphthalen-2-yl 1-thio-beta-D-galactopyranoside | 4 |
| IE3 | [3-[(2~{S},3~{R},4~{S},5~{R},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]sulfanyl-4-methoxy-phenyl]-(3,4,5-trimethoxyphenyl)methanone | 4 |